Leading the Way in Life Science Technologies

GEN Exclusives

More »

GEN News Highlights

More »
Mar 26, 2009

VWR Extends Distribution Deal Covering ZyGEM’s DNA Extraction Technology to Europe

  • VWR International Europe obtained rights to distribute ZyGEM's DNA extraction kits in Europe. VWR has been distributing ZyGEM's DNA extraction kits in North and South America since November 2008. Under the terms of the new nonexclusive license, VWR will be able to supply the DNA extraction products to the life science research, forensic, agriculture, and animal health markets throughout Europe.

    ZyGEM's technology uses a thermophilic enzyme to extract DNA from samples using a single closed-tube system. This approach reportedly reduces the time and cost of DNA extractions while simplifying laboratory workflow, minimizing error, reducing the risk of contamination, ensuring sample integrity, and facilitating extractions from trace samples.



Related content

Be sure to take the GEN Poll

Scientifically Studying Ecstasy

MDMA (commonly known as the empathogen “ecstasy”) is classified as a Schedule 1 drug, which is reserved for compounds with no accepted medical use and a high abuse potential. Two researchers from Stanford, however, call for a rigorous scientific exploration of MDMA's effects to identify precisely how the drug works, the data from which could be used to develop therapeutic compounds.

Do you agree that ecstasy should be studied for its potential therapeutic benefits?

More »